Eli Lilly (NYSE: LLY) has been on a tear for the better part of the last decade, but the company has experienced a bit of a ...

On Oct. 30, Eli Lilly will announce third-quarter earnings results that could lift the stock, or pressure it further. Here ...

These companies are investing heavily into their pipelines and the payoff for long-term investors can be substantial.

Discover why Viking Therapeutics, Inc.'s VK2735 could lead GLP-1 obesity drugs. Click for my updated look at VKTX stock ...

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

What is believed to be the world's largest seizure of counterfeit weight loss jabs has taken place in the UK.

Officers in Northampton also found ‘sophisticated packaging and manufacturing equipment’ as well as £20,000 in cash.

Health Secretary Wes Streeting has warned people not to buy weight-loss jabs from unregulated sources after an illegal ...

Some guys are getting this promising new weight loss drug on the grey market. Here's what it does and the risks of taking it ...

Most effective drugs for obesity and its complications are semaglutide, tirzepatide, new European guideline says Certain GLP-1 drugs are best for specific complications The non-binding guideline ...

The European Association for the Study of Obesity recommends the GLP-1 injectables semaglutide and tirzepatide as first-line treatments for most cases of obesity. This is due to their higher efficacy ...

Stay updated on stocks to watch as key defence, pharma, and manufacturing firms announce major deals and approvals—read the latest market movers!